glp 1 bone density GLP-1s and loss! Positive impact of GIP, GLP-1

The secondary renal outcome was a composite of the following components: new-onset persistent macroalbuminuria, persistent doubling of the serum creatinine level, ESRD, or death due to renal disease

Expected side effects at prescribed doses include nausea, vomiting, diarrhea and abdominal pain

Compound 36 also exhibited good efficacy in oral glucose tolerance tests, demonstrating great DPP-4 inhibitory activity (IC 50 = 0.017 M) and moderate selectivity against DPP-4 in both ICR and KKAy mice

8 Small amounts of GLP-1 may also be produced by preproglucagon neurons, located in the nucleus tractus solitarii of the brainstem 26,27 and projected to other brain regions, such as the nuclei of the hypothalamus, including the arcuate and paraventricular nuclei

2 Since it is non-peptide, orforglipron avoids GI degradation barriers that limit peptides, thereby enabling once-daily administration while maintaining efficacy on glucose control, body weight, and tolerability

For some people who are doing well and tolerating the medication, a lower maintenance dose may be part of the plan